A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

NCT07656415 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Mitapivat Matched Placebo
DRUG: Mitapivat

Sponsor

Agios Pharmaceuticals, Inc.